Skip to main content
Pop Culture

Chris Evert Fights Ovarian Cancer Again: A Champion's Third Round

Local LawtonAuthor
Published
Reading time2 min
Share:

Some battles don’t stay won. Tennis legend Chris Evert learned that painful truth this past weekend when CT and PET scans revealed her ovarian cancer has returned — marking the third time the 71-year-old has faced down this particular opponent.

If the news landed hard, Evert’s response landed harder. In a statement that mixed unflinching honesty with the same mental toughness that defined her 18 Grand Slam career, she announced she’s already undergone surgery and will start chemotherapy in the coming weeks. She’s also skipping Wimbledon this year, the London tournament she won three times (1974, 1976, 1981) — a decision that underscores just how serious this battle is.

What makes Evert’s public stand noteworthy isn’t just her determination, though that’s certainly part of it. It’s her willingness to speak plainly about recurrence at all. Cancer comebacks don’t fit the triumphant narrative we’re conditioned to expect. The disease returning after previous victories can feel like failure, or worse, a sentence. But Evert’s framing —“Ovarian cancer is relentless, but I will stay optimistic and determined in continuing to fight this battle”— redefines the conversation. She’s not pretending this is easy or predetermined. She’s naming it as hard and fighting anyway.

She’s beaten this before, in 2021 and 2023. The odds of a third victory aren’t the kind anyone wants to contemplate. But if there’s one thing a three-time Wimbledon champion knows, it’s how to show up when the pressure is maximum and the margin for error is zero. This time, the court is her body. The opponent is a disease that doesn’t follow the rules of sport. And the stakes are clearer than they’ve ever been.

The tennis world has lost a lot of legends over the years. Evert isn’t done yet.

About the Author

Local Lawton

Local Lawton is a contributor to LocalBeat, covering local news and community stories.

Share:

Related Stories